← Back to Search

CTC Intervention for High Blood Pressure

N/A

Waitlist Available

Led By Sarah L Cutrona, MD

Research Sponsored by VA Office of Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6-months after intervention

Awards & highlights

Study Summary

This trial is designed to see if improving hypertension self-management and lowering blood pressure (BP) in African-American Veterans is possible by having them watch videos and then receive text messages related to the content of the videos.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6-months after intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6-months after intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-months after intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

BP Measurement Change at Follow-up

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: CTCExperimental Treatment1 Intervention

An integrated peer narrative-based intervention (VIEW > SELECT > GET), beginning with VIEW In-person viewing of VA Stories narratives, followed by SELECT a favorite Veteran] Storyteller, and then GET favorite Storyteller "narrative-aligned" text messages over 6 months

Group II: ControlActive Control1 Intervention

6-month HTN management assessment text messages without narrative component

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

CTC Intervention

2020

N/A

~600

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor

1,609 Previous Clinical Trials

3,306,003 Total Patients Enrolled

Sarah L Cutrona, MDPrincipal InvestigatorVA Bedford HealthCare System, Bedford, MA

Media Library

Control Clinical Trial Eligibility Overview. Trial Name: NCT03970590 — N/A

High Blood Pressure Research Study Groups: CTC, Control

High Blood Pressure Clinical Trial 2023: Control Highlights & Side Effects. Trial Name: NCT03970590 — N/A

Control 2023 Treatment Timeline for Medical Study. Trial Name: NCT03970590 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are being included in the research program?

"Affirmative. According to clinicaltrials.gov, this investigation is actively accepting participants. The study was first published on November 30th 2020 and has been restlessly revised since then; 600 people are needed across two experiment sites."

Answered by AI

Is there capacity within this trial for additional participants?

"This medical trial, first posted on November 30th 2020 and last updated April 7th 2022 is currently enrolling patients, as indicated by the clinicaltrials.gov listing."

Answered by AI

Recent research and studies

JMIR Research ProtocolsJournal

Incorporating African American Veterans’ Success Stories for Hypertension Management: Developing a Behavioral Support Texting Protocol

DeLaughter, Kathryn L, Gemmae M Fix, Sarah E McDannold, Charlene Pope, Barbara G Bokhour, Stephanie L Shimada, Rodney Calloway, et al.. 2021. “Incorporating African American Veterans’ Success Stories for Hypertension Management: Developing a Behavioral Support Texting Protocol”. JMIR Research Protocols. JMIR Publications Inc.. doi:10.2196/29423.

clinicaltrials.govStudy

Continuing the Conversation: Using Narrative Communication to Support Hypertension Self-management in African American Veterans

2020. "Continuing the Conversation: Using Narrative Communication to Support Hypertension Self-management in African American Veterans". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03970590.